Arthralgia adverse events due to immune-checkpoint inhibitors for lung cancer patients: a systematic review and meta-analysis

BACKGROUND: Immune agents targeting Programmed cell death-1 (PD-1) are a new type of cancer treatment drugs. By inhibiting the interaction between PD-1 and PD-L1, the ability of the immune system to attack tumor cells is enhanced. These immune preparations have shown significant efficacy in the trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Defang, Wang, Xiaoping, Sun, Yamin, Wang, Xi, Lu, Chang, Wang, Aiyun, Wang, Xia, Yang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576430/
https://www.ncbi.nlm.nih.gov/pubmed/37841432
http://dx.doi.org/10.3389/fonc.2023.1258287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576430/
https://www.ncbi.nlm.nih.gov/pubmed/37841432
http://dx.doi.org/10.3389/fonc.2023.1258287

Ejemplares similares